References
- Murtaza B, Hichami A, Khan AS, Ghiringhelli F, Khan NA. Alteration in Taste Perception in Cancer: Causes and Strategies of Treatment. Front Physiol. 2017;8(134):134.
- Hutton JL, Baracos VE, Wismer WV. Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage. 2007;33(2):156–65. doi:https://doi.org/10.1016/j.jpainsymman.2006.07.017
- Nolden AA, Hwang LD, Boltong A, Reed DR. Chemosensory Changes from Cancer Treatment and Their Effects on Patients’ Food Behavior: A Scoping Review. Nutrients. 2019;11(10):2285. doi:https://doi.org/10.3390/nu11102285
- Ryan AM, Prado CM, Sullivan ES, Power DG, Daly LE. Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival. Nutrition. 2019;67-68:110539. doi:https://doi.org/10.1016/j.nut.2019.06.020
- Battle D, Rathmell WK, Jonasch E, Msaouel P, Stern AP, Zhang T, George DJ, Staehler MD. Patient-reported outcomes on treatment-related side effects in renal cell carcinoma. JCO. 2020; 38(6_suppl):654. doi:https://doi.org/10.1200/JCO.2020.38.6_suppl.654
- Sevryugin O, Kasvis P, Vigano M, Vigano A. Taste and smell disturbances in cancer patients: a scoping review of available treatments. Support Care Cancer. 2021;29(1):49–66. doi:https://doi.org/10.1007/s00520-020-05609-4
- Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol. 2010;46(2):77–81. doi:https://doi.org/10.1016/j.oraloncology.2009.11.008
- Kano T, Kanda K. Development and validation of a chemotherapy-induced taste alteration scale. Oncol Nurs Forum. 2013;40(2):E79–85. doi:https://doi.org/10.1188/13.ONF.E79-E85
- Campagna S, Gonella S, Stuardi M, Sperlinga R, Cerponi M, et al. Validazione italiana della Chemotherapy induced Taste Alteration Scale (CiTAS) [Italian validation of the Chemotherapy Induced Taste Alteration Scale]. Assist Inferm Ric. 2016;35:22–8.
- Simeone S, Esposito MR, Gargiulo G, Lanzuise A, Botti S, Serra N, Continisio GI, Rea T, Guillari A. The CiTAS scale for evaluating taste alteration induced by chemotherapy: state of the art on its clinical use. Acta Biomed. 2019;90(6-S):17–25.
- Spotten LE, Corish CA, Lorton CM, Ui Dhuibhir PM, O’Donoghue NC, O’Connor B, Walsh TD. Subjective and objective taste and smell changes in cancer. Ann Oncol. 2017;28(5):969–984. doi:https://doi.org/10.1093/annonc/mdx018
- Elia M. Screening for malnutrition: A multidisciplinary responsibility. Development and Use of the Malnutrition Universal Screening Tool (‘MUST’) for Adults. Redditch: BAPEN; 2003.
- Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, Mendoza TR, Hay J, Atkinson TM, Abernethy AP, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106(9):dju244–dju244. doi:https://doi.org/10.1093/jnci/dju244
- Boltong A, Keast R. Chemosensory Science in the Context of Cancer Treatment: Implications for Patient Care. Chem Percept. 2015;8(3):117–25. doi:https://doi.org/10.1007/s12078-015-9180-0
- Watters AL, Epstein JB, Agulnik M. Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol. 2011;47(6):441–8. doi:https://doi.org/10.1016/j.oraloncology.2011.03.028
- IJpma I, Timmermans ER, Renken RJ, Ter Horst GJ, Reyners AK. Metallic Taste in Cancer Patients Treated with Systemic Therapy: A Questionnaire-based Study. Nutr Cancer. 2017;69(1):140–45. doi:https://doi.org/10.1080/01635581.2017.1250922
- Ovesen L, Hannibal J, Sørensen M, Allingstrup L. Food intake, eating-related complaints, and smell and taste sensations in patients with cancer of the lung, ovary and breast undergoing chemotherapy. Clin Nutr. 1991;10(6):336–41. doi:https://doi.org/10.1016/0261-5614(91)90063-i
- Boers-Doets CB, Epstein JB, Raber-Durlacher JE, Ouwerkerk J, Logan RM, Brakenhoff JA, Lacouture ME, Gelderblom H. Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review. Oncologist. 2012;17(1):135–44. doi:https://doi.org/10.1634/theoncologist.2011-0111
- Kaizu M, Komatsu H, Yamauchi H, Yamauchi T, Sumitani M, Doorenbos AZ. Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life. Support Care Cancer. 2021;29(9):5103–5114. doi:https://doi.org/10.1007/s00520-021-06066-3
- Larsen AK, Thomsen C, Sanden M, Skadhauge LB, Anker CB, Mortensen MN, Bredie WLP. Taste alterations and oral discomfort in patients receiving chemotherapy. Support Care Cancer. 2021;29(12):7431–7439. doi:https://doi.org/10.1007/s00520-021-06316-4
- Rea T, Esposito MR, Simeone S, Guillari A, Tessitore G, Lanzuise A, Bosco G, Gargiulo G, Coratella C, Scarlata F, et al. An investigation of taste alteration in patients undergoing cancer chemotherapy. Gazz Med Ital - Arch Sci Med. 2018;177(10):509–17. doi:https://doi.org/10.23736/S0393-3660.18.03810-X
- Martini S, Iorio GC, Arcadipane F, Olivero F, Silvetti P, Rampino M, Garzino Demo P, Fasolis M, Pecorari G, Airoldi M, et al. Prospective assessment of taste impairment and nausea during radiotherapy for head and neck cancer. Med Oncol. 2019;36(5):44. doi:https://doi.org/10.1007/s12032-019-1269-x
- Chan CW, Chang AM, Molassiotis A, Lee IY, Lee GC. Oral complications in Chinese cancer patients undergoing chemotherapy. Support Care Cancer. 2003;11(1):48–55. doi:https://doi.org/10.1007/s00520-002-0413-9
- Dent E, Hoogendijk EO, Visvanathan R, Wright ORL. Malnutrition screening and assessment in hospitalised older people: a review. J Nutr Health Aging. 2019;23(5):431–41. doi:https://doi.org/10.1007/s12603-019-1176-z
- Ackerman D, Laszlo M, Provisor A, Yu A. Nutrition management for the head and neck cancer patient. Cancer Treat Res. 2018;174:187–208. doi:https://doi.org/10.1007/978-3-319-65421-8_11